{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:31:42Z","timestamp":1762900302976},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,10]]},"DOI":"10.7759\/cureus.25814","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T11:13:18Z","timestamp":1654859598000},"source":"Crossref","is-referenced-by-count":5,"title":["Histiocytic Sarcoma: Clinical Features and Outcomes of Patients Treated at a Tertiary Cancer Care Center"],"prefix":"10.7759","author":[{"given":"Deepa","family":"Susan Joy Philip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amitha","family":"Sherief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geetha","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreejith G","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayasudha","family":"AV","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.53.1","article-title":"Histiocytic sarcoma : an updated literature review based on the 2008 WHO classification","volume":"53","author":"Takahashi E","year":"2013","unstructured":"Takahashi E, Nakamura S. Histiocytic sarcoma : an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop. 2013, 53:1-8. 10.3960\/jslrt.53.1","journal-title":"J Clin Exp Hematop"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2002.01418.x","article-title":"Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases","volume":"41","author":"Pileri SA","year":"2002","unstructured":"Pileri SA, Grogan TM, Harris NL, et al.. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002, 41:1-29. 10.1046\/j.1365-2559.2002.01418.x","journal-title":"Histopathology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1492128","article-title":"Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma","volume":"60","author":"Kommalapati A","year":"2019","unstructured":"Kommalapati A, Tella SH, Go RS, Goyal G. Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma. Leuk Lymphoma. 2019, 60:553-5. 10.1080\/10428194.2018.1492128","journal-title":"Leuk Lymphoma"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-017-2176-1","article-title":"Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases","volume":"471","author":"Facchetti F","year":"2017","unstructured":"Facchetti F, Pileri SA, Lorenzi L, et al.. Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases. Virchows Arch. 2017, 471:467-89. 10.1007\/s00428-017-2176-1","journal-title":"Virchows Arch"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12755","article-title":"Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment","volume":"97","author":"Ansari J","year":"2016","unstructured":"Ansari J, Naqash AR, Munker R, et al.. Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment. Eur J Haematol. 2016, 97:9-16. 10.1111\/ejh.12755","journal-title":"Eur J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/98927-histiocytic-sarcoma-clinical-features-and-outcomes-of-patients-treated-at-a-tertiary-cancer-care-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:58Z","timestamp":1707507418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/98927-histiocytic-sarcoma-clinical-features-and-outcomes-of-patients-treated-at-a-tertiary-cancer-care-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.25814","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,10]]}}}